COVID-19 screening start-up Curative Inc. revealed the launch of new COVID-19 research in the City of San Antonio. The study intends to comprehend better just how video-assisted self-collected oral swab samples and nasal swab samples contrast to provider-collected nasal swab samples to detect COVID-19. If proven right, the self-collected COVID-19 tests will minimize dependence on the supply of individual safety tools (masks, gloves, and laboratory coats) and protect against prospective direct exposure of our physicians or nurses to unique Coronavirus. The self-collected COVID-19 tests research will be conducted on 5,000 asymptomatic patients in San Antonio.
This study of potential asymptomatic cases is key to furthering the fight against this pandemic. We would like to thank our strategic partner, Curative, for taking the lead on this initiative. – said San Antonio Assistant City Manager Dr. Colleen Bridger
The symptoms consist of shortness of breath, difficulty in breathing, or coughing. Those who participate in the study might need to do a self-collected oral and nasal swab, blood sample, medical professional accumulated nasal, and nasopharyngeal (NP) swab.
The more we can use self-collected tests, we minimize resources required, expand testing capabilities, and ultimately track and treat as needed. – said Fred Turner, CEO of Curative
Curative Inc. expands accessibility to screening via future generation testing with mobile vans and kiosks throughout Texas, consisting of remote locations. It also recently opened a brand-new CLIA-certified research laboratory center based in Pflugerville, Texas, to raise both availability and handle the state’s capacity to conduct 10,000 examinations each day and utilize the company’s FDA licensed oral liquid COVID-19 examination. The test is simple and pain-free, with turn-around time within 48 hrs.